Lymphoma - Clinical Research

Organisational unit: Research group

Research areas and keywords

UKÄ subject classification

  • Cancer and Oncology

Keywords

  • Lymphoma

Research

The area of research for our group is malignant lymphomas – aiming for the improvement of the quality of life and survival of these patients. The paradigm behind most of current health care is evidence –based medicine. The evidence basis is primarily derived from clinical trials, but data can also be extracted from alternate sources such as national or regional data registries. The objective of our research is to expand this evidence basis, currently through three strategies: 1. The development of cIinical trials - we have been involved in all stages of trials for lymphoma, and designed, conducted and initiated several. 2. Clinical epidemiology – using data from the Swedish Lymphoma Registry to provide clinically useful real world data on treatment and prognosis, in many cases in collaboration with Nordic colleagues. 3. Translational research – to identify predictive biomarkers for treatment decision – by immunohistochemistry, gene expression or sequencing.

Recent research outputs

Fatemeh Saberi Hosnijeh, Delphine Casabonne, Alexandra Nieters, Marta Solans, Sabine Naudin, Pietro Ferrari, James D. Mckay, Yolanda Benavente, Elisabete Weiderpass, Heinz Freisling, Gianluca Severi, Marie Christine Boutron Ruault, Caroline Besson, Claudia Agnoli, Giovanna Masala, Carlotta Sacerdote, Rosario Tumino, José María Huerta, Pilar Amiano, Miguel Rodriguez-Barranco & 15 others, Catalina Bonet, Aurelio Barricarte, Sofia Christakoudi, Anika Knuppel, Bas Bueno-de-Mesquita, Matthias B. Schulze, Rudolf Kaaks, Federico Canzian, Florentin Späth, Mats Jerkeman, Charlotta Rylander, Anne Tjønneland, Anja Olsen, Kristin Benjaminsen Borch & Roel Vermeulen, 2021, In: International Journal of Cancer. 148, 9, p. 2115-2128

Research output: Contribution to journalArticle

Adam J. Olszewski, Lasse H. Jakobsen, Graham P. Collins, Kate Cwynarski, Veronika Bachanova, Kristie A. Blum, Kirsten M. Boughan, Mark Bower, Alessia Dalla Pria, Alexey Danilov, Kevin A. David, Catherine Diefenbach, Fredrik Ellin, Narendranath Epperla, Umar Farooq, Tatyana A. Feldman, Alina S. Gerrie, Deepa Jagadeesh, Manali Kamdar, Reem Karmali & 29 others, Shireen Kassam, Vaishalee P. Kenkre, Nadia Khan, Seo Hyun Kim, Andreas K. Klein, Izidore S. Lossos, Matthew A. Lunning, Peter Martin, Nicolas Martinez-Calle, Silvia Montoto, Seema Naik, Neil Palmisiano, David Peace, Elizabeth H. Phillips, Tycel J. Phillips, Craig A. Portell, Nishitha Reddy, Anna Santarsieri, Maryam Sarraf Yazdy, Knut B. Smeland, Scott E. Smith, Stephen D. Smith, Suchitra Sundaram, Adam S. Zayac, Xiao Yin Zhang, Catherine Zhu, Chan Y. Cheah, Tarec C. El-Galaly & Andrew M. Evens, 2021, In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 39, 10, p. 1129-1138 10 p.

Research output: Contribution to journalArticle

Lasse Hjort Jakobsen, Torbjörn Callréus, Maurizio Sessa, Mats Jerkeman, Morten Andersen & Tarec Christoffer El-Galaly, 2021, In: Pharmacoepidemiology and Drug Safety.

Research output: Contribution to journalArticle

View All (60)